Pilot Study Comparing Treatment With Dexmedetomidine to Midazolam for Symptom Control in Advanced Cancer Patients

NCT01687751 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Study design determined to be not likely feasible

Conditions

Pain Intractable
Delirium
Dyspnea
Nausea

Interventions

DRUG: Dexmedetomidine
DRUG: Midazolam

Sponsor

Fraser Health